Central Carbon Metabolic Flux Analysis Service - Creative Proteomics Metabolomics

Q: How is [1,2‑13C2]glucose used to evaluate the glycolysis vs. pentose phosphate pathway split?

When [1,2‑13C2]glucose is processed directly through glycolysis, both labeled carbons are retained together, yielding M+2 lactate and pyruvate. When glucose enters the oxidative pentose phosphate pathway, decarboxylation at G6PDH/6PGD releases carbon‑1 as 13CO2, yielding [1‑13C]pentose phosphate that can re‑enter glycolysis to form M+1 lactate and pyruvate. Incorporating these diagnostic labeling fractions into a constrained model allows mathematical estimation of relative pathway routing.

Q: How are pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC) fluxes distinguished?

Using [U‑13C6]glucose, PDH decarboxylates M+3 pyruvate to form M+2 acetyl‑CoA, condensing with oxaloacetate to generate M+2 citrate. In parallel, PC carboxylates M+3 pyruvate into M+3 oxaloacetate, producing M+3 malate, aspartate, and M+3/M+5 citrate. Comparing these distinct isotopologue patterns in a stoichiometric network model permits estimation of the PDH versus PC anaplerotic split.

Q: What analytical platforms are used for central carbon isotopologue measurement?

Depending on target coverage and sample matrix, high‑resolution LC‑MS is typically applied for intact phosphorylated intermediates (e.g. G6P, FBP, PEP) and organic acids, while GC‑MS with silylation derivatization is used for fragment‑specific measurements of organic acids and amino acids. Analytical platform selection is finalized during project feasibility review.

Central Carbon Metabolic Flux Analysis — Beyond Static Pool Concentrations

Central carbon metabolism coordinates cellular energetics and precursor synthesis across glycolysis, the pentose phosphate pathway (PPP), and the tricarboxylic acid (TCA) cycle. While conventional metabolomics quantifies static pool sizes (μmol/g or ng/mL), concentration data alone cannot determine whether intermediate accumulation reflects accelerated upstream synthesis, impaired downstream consumption, or branch-point rerouting.

As a core pathway pillar within our metabolic flux analysis service, Central Carbon MFA tracks stable carbon isotopes (¹³C) to model intracellular reaction rates and pathway partitioning:

(i) Glycolysis vs. Pentose Phosphate Pathway Split: Carbon routing at the glucose-6-phosphate (G6P) node, detailed in our pentose phosphate pathway metabolic flux analysis.

(ii) Pyruvate Partitioning & Anaplerosis: Mitochondrial carbon entry through pyruvate dehydrogenase (PDH) versus pyruvate carboxylase (PC), connected to our glycolytic pathway metabolic flux analysis.

(iii) TCA Cycle Directionality: Forward oxidative TCA cycling versus IDH-mediated reductive carboxylation, evaluated in our TCA cycle metabolic flux analysis.

(iv) Biosynthetic Diversion: One-carbon and serine/glycine synthesis from 3-phosphoglycerate (3-PG) under genetic, nutritional, or pharmacological perturbations.

Looking for metabolite concentration measurements? If your study focuses on quantifying absolute or relative metabolite pool sizes (μmol/g or ng/mL) rather than dynamic pathway fluxes, please explore our Central Carbon Metabolism Analysis service.

Analytical Considerations & Feasibility for Central Carbon Fluxomics

Central carbon fluxomics requires tailored bioanalytical strategies across polar phosphorylated intermediates, carboxylic acids, and amino acids:

System-Tailored Metabolic Arrest: Rapid solvent quenching and extraction protocols are selected based on the matrix (adherent cells, suspension cultures, microbial biomass, or tissue specimens) to preserve intermediate integrity.
High-Resolution Mass Spectrometry: LC-MS and GC-MS platforms are matched to analytical targets to separate key isotopologue envelopes from matrix interferences without derivatization bias for phosphorylated intermediates.
Natural Abundance Deconvolution: Algorithmic matrix correction (such as IsoCor or AccuCor routines) corrects raw mass spectra for natural isotopic background (¹³C, ¹⁵N, ¹⁸O, and silyl tags) prior to model fitting.
Extracellular Boundary Constraints: Concurrently measured substrate uptake (e.g. glucose, glutamine) and byproduct secretion rates (e.g. lactate, alanine) anchor the mathematical model to absolute physical scales.

Stable-Isotope 13C Tracer Strategies for Central Carbon Flux Tracing

Tracer selection is evaluated during feasibility review to align labeling contrast with your pathway hypotheses:

Tracer Substrate	Target Pathway Node	Diagnostic Labeling Information
[1,2-¹³C₂]Glucose	Glycolysis vs. Oxidative Pentose Phosphate Pathway (oxPPP)	Direct glycolysis yields M+2 downstream triose phosphates and lactate (retaining C1-C2 intact), whereas oxPPP decarboxylation of C1 yields M+1 pentose phosphates and downstream M+1 lactate. Provides diagnostic labeling contrast that can support estimation of glycolytic and oxidative PPP routing when incorporated into an appropriately constrained network model.
[U-¹³C₆]Glucose	Glycolytic throughput, PDH vs. PC entry into TCA, and serine synthesis	Uniformly labels glycolytic intermediates (M+3 trioses, M+3 pyruvate/lactate). Pyruvate dehydrogenase (PDH) entry produces M+2 acetyl-CoA and M+2 citrate, whereas pyruvate carboxylase (PC) anaplerosis yields M+3 oxaloacetate and M+3/M+5 citrate.
[U-¹³C₅]Glutamine	Oxidative TCA cycling vs. Reductive Carboxylation	Deamination yields [U-¹³C₅]α-KG (M+5). Forward oxidative cycling produces M+4 succinate, fumarate, malate, and citrate; reverse reductive carboxylation catalyzed by IDH produces M+5 citrate and M+3 malate.
Parallel [1-¹³C] + [U-¹³C₆]Glucose	Global network identifiability and exchange reversibility	Parallel tracer experiments and joint model fitting can resolve transketolase/transaldolase reversible exchange fluxes alongside anaplerosis within our 13C metabolic flux analysis framework.

Technical Platform Capabilities for Central Carbon MFA

Orthogonal Analytical Platforms: Tailored deployment of high-resolution LC-MS for intact phosphorylated intermediates alongside GC-MS-based metabolic flux analysis for fragment-resolved amino acid and organic acid isotopologues.
Isotopic Steady-State and Dynamic Options: Supports conventional isotopic steady-state ¹³C-MFA as well as time-course sampling for dynamic and INST metabolic flux analysis where pool turnover or growth transitions preclude isotopic equilibrium.
Statistical Identifiability and Uncertainty Analysis: Fitted fluxes are evaluated with goodness-of-fit testing and confidence interval assessments to distinguish well-constrained parameters from unidentifiable reactions.
Complementary Positional Validation: Where position-specific carbon atom transitions require orthogonal physical verification, studies can incorporate high-field NMR-based metabolic flux analysis.

End-to-End Central Carbon MFA Workflow & Analytical Pipeline

Feasibility Assessment & Network Scoping

We define the stoichiometric reaction network, carbon atom transitions, and candidate tracer configurations matched to your biological system and research questions.

Tracer Incubation & Sample Quenching

Experimental cultures are labeled with validated ¹³C tracers and rapidly harvested using pre-evaluated quenching protocols to preserve intracellular intermediate states.

Mass Spectrometry Data Acquisition

Mass isotopologue distributions (M+0 to M+n) are acquired on LC-MS and GC-MS platforms; extracellular consumption and secretion rates are quantified from matched media samples.

Natural Abundance Correction & QC Review

Raw mass isotopologue fractions are algorithmically corrected for natural isotopic background, with chromatographic peak quality and replicate consistency audited across batches.

Mathematical Modeling & Uncertainty Estimation

Stoichiometric and isotopomer balance equations are fitted to experimental data, followed by goodness-of-fit evaluation and parameter confidence interval estimation.

Flux Maps & Technical Reporting

Results are delivered as structured data tables, model diagnostics, and publication-oriented pathway flux maps supported by our fluxomics data analysis service.

Six-step workflow for central carbon metabolic flux analysis

Sample Preparation & Submission Guidelines for Central Carbon MFA

Sample amounts and quenching procedures are finalized during feasibility review based on intermediate abundance, turnover kinetics, and matrix type:

Sample Type	Typical Input Guidelines	Harvesting & Quenching Principles	Storage & Transport
Adherent Cultured Cells	Typically 1–10 × 10⁶ cells per replicate, confirmed by pilot assessment	Rapid medium removal, immediate addition of pre-chilled organic extraction solvent, cell detachment on dry ice/ice. Minimize wash duration.	Store at −80 °C; ship on dry ice
Suspension Cultured Cells	Typically 2–10 × 10⁶ cells, adjusted to cell size and density	Short, pre-cooled centrifugation or direct cold solvent quenching, rapid supernatant removal, and immediate solvent extraction.	Store at −80 °C; ship on dry ice
Microbial & Fermentation Pellets	Biomass volume determined by pilot extraction and target coverage	Fast filtration or direct quenching into pre-chilled solvent to arrest fast-turnover pools. Retain spent medium for extracellular rate quantification.	Store at −80 °C; ship on dry ice
Plant & Animal Tissue Specimens	20–100 mg wet weight, depending on metabolic activity	Immediate freeze-clamping or flash freezing in liquid nitrogen upon collection; cryogenic pulverization without intermediate thawing.	Store at −80 °C; ship on dry ice
Conditioned Culture Medium	≥ 200 μL matched supernatant	Collect from matched labeling time points, clarify by centrifugation to remove cellular debris, aliquot for extracellular rate profiling.	Store at −80 °C; ship on dry ice

Quantifiable Deliverables from Central Carbon Metabolic Flux Analysis

Corrected Mass Isotopologue Distribution Data: Natural-abundance-corrected fractional labeling (M+0 to M+n) across central pathway intermediates (.csv / Excel).
Extracellular Rate Measurements: Quantified substrate uptake and product secretion rates providing stoichiometric boundaries for flux calculation.
Model Specifications & Network Files: Reaction network definitions, carbon atom transition mappings, and project configuration files.
Fitted Flux Estimates & Uncertainty Ranges: Calculated net and exchange fluxes with accompanying sensitivity analysis and confidence intervals.
Goodness-of-Fit Diagnostics: Residual distributions, Chi-square statistics, and measured-versus-simulated correlation plots.
Pathway Flux Visualizations: Publication-oriented network diagrams representing central carbon partitioning with flux-scaled annotations.

Representative central carbon mass isotopologue distribution bar chart

Representative central carbon mass isotopologue distribution (MID) bar plot displaying natural-abundance-corrected fractional labeling across glycolysis and TCA intermediates.

Central carbon metabolic flux map with reaction rate and confidence annotations

Publication-oriented central carbon metabolic flux map illustrating estimated pathway rates, branch-point split ratios, and quantitative uncertainty annotations.

Research Applications of Central Carbon Pathway Flux Analysis

Cellular Metabolic Phenotyping: Characterize alterations in glucose catabolism, glutamine utilization, and anaplerotic pathways across wild-type, mutant, or drug-treated conditions.
Bioprocess & Metabolic Engineering: Identify pathway bottlenecks, evaluate carbon yield toward target products, and monitor overflow metabolism in fermentation hosts.
Immunometabolism Studies: Map metabolic shifts between oxidative phosphorylation and aerobic glycolysis during immune cell activation or differentiation.
Nutrient Adaptation & Stress Response: Quantify carbon redistribution under nutrient limitation, hypoxia, or environmental challenges in mammalian, microbial, or plant systems.

How does Central Carbon MFA differ from standard targeted metabolomics?

Targeted metabolomics measures static metabolite pool concentrations (μmol/g or ng/mL) at a specific sampling point. In contrast, Central Carbon MFA introduces stable-isotope tracers (such as ¹³C-labeled glucose or glutamine) to track carbon transitions over time or at isotopic steady state, using mathematical network models to calculate intracellular pathway fluxes and split ratios across glycolysis, PPP, and the TCA cycle.

How is [1,2-¹³C₂]glucose used to evaluate the glycolysis vs. pentose phosphate pathway split?

When [1,2-¹³C₂]glucose is processed directly through glycolysis, both labeled carbons are retained together, yielding M+2 lactate and pyruvate. When glucose enters the oxidative pentose phosphate pathway, decarboxylation at G6PDH/6PGD releases carbon-1 as ¹³CO₂, yielding [1-¹³C]pentose phosphate that can re-enter glycolysis to form M+1 lactate and pyruvate. Incorporating these diagnostic labeling fractions into a constrained model allows mathematical estimation of relative pathway routing.

How are pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC) fluxes distinguished?

Using [U-¹³C₆]glucose, PDH decarboxylates M+3 pyruvate to form M+2 acetyl-CoA, condensing with oxaloacetate to generate M+2 citrate. In parallel, PC carboxylates M+3 pyruvate into M+3 oxaloacetate, producing M+3 malate, aspartate, and M+3/M+5 citrate. Comparing these distinct isotopologue patterns in a stoichiometric network model permits estimation of the PDH versus PC anaplerotic split.

What analytical platforms are used for central carbon isotopologue measurement?

Depending on target coverage and sample matrix, high-resolution LC-MS is typically applied for intact phosphorylated intermediates (e.g. G6P, FBP, PEP) and organic acids, while GC-MS with silylation derivatization is used for fragment-specific measurements of organic acids and amino acids. Analytical platform selection is finalized during project feasibility review.

How are estimated fluxes normalized and validated?

Calculated fluxes are anchored to experimentally measured extracellular substrate uptake and product secretion rates normalized to biomass (e.g. mmol/gDW/h) or cell count. Model fits are evaluated using goodness-of-fit criteria and parameter sensitivity analysis to verify that reported fluxes are well supported by the experimental dataset.